In the STEP UP trial, adults living with obesity who took Wegovy 7.2 mg lost an average of 20.7% of their body weight over 72 weeks, and around one in three lost at least 25%
Speers AB, Cabey KA, Soumyanath A, et al
The molecular mechanism of chronic inflammation-driven aging involves intricate crosstalk among multiple signaling axes within a distinct pathophysiological context
GLP 1 Obesity and Diabetes 40% carbs, 35% protein & 25% fat Calorie Ranges 1200, 1400, 1600, 1800 Creator: Suzanne Fisher, LD RD The Obesity and Diabetes GLP-1 meal plan caters to individuals with comorbidities of obesity and diabetes
Learn about best peptide vendors with detailed comparisons, Amopure review for budget alternative, and getting started with peptides for beginners
For a complete overview of getting Wegovy covered regardless of insurer, see our full coverage guide